Company: GANX
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001104659-25-068530
Chunk: 2

Company: Gain Therapeutics, Inc.
Filing Date: 2025-07-17
Form: 8-K
Item: Item 1.01
Chunk 2
---
’s Warrants provide for piggyback registration rights
expiring five (5) years from the date of the Underwriting Agreement.

The Company will also enter into a warrant agent agreement with the
Company’s transfer agent, Pacific Stock Transfer Company (the “ Warrant Agent”), which will act as warrant agent
for the Company, setting forth certain terms and conditions with respect to the Warrant Agent’s service as warrant agent for the
Warrants (the “Warrant Agent Agreement”).

The Offering is expected to close on or about July 17, 2025, subject
to the satisfaction of customary closing conditions.

The foregoing description of the Underwriting Agreement, the Warrants,
the Underwriter’s Warrants and the Warrant Agent Agreement is not complete and is subject to, and qualified in its entirety by,
reference to the full text of the Underwriting Agreement, the form of Warrant, the form of Underwriter’s Warrant and the form of
Warrant Agent Agreement, which are filed as Exhibits 1.1, 4.1, 4.2 and 4.3, respectively, to this Current Report on Form 8-K and are incorporated
by reference herein.

The opinion of Lowenstein Sandler LLP regarding the validity of
the securities to be issued in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.

Item 3.02 Unregistered Sales of Equity Securities.